Currently, mechanisms and therapeutic approaches have been thoroughly studied in
various prevalent malignant tumors, such as breast and lung cancer. However, there is …

Background The contribution of hepatitis B virus (HBV) and hepatitis C virus (HCV) to
primary liver cancer (PLC) and their association with cancer aggressiveness remains …

BACKGROUND A wide range of ablative and non-surgical therapies are available for
treating small hepatocellular carcinoma in patients with very early or early-stage disease …

Background and Aims To explore the long-term trend of liver cancer survival, based on the
real-world data (RWD) in the past 45 years from a population-based cancer registry, in …

Background The clinical benefits of treatment with radiofrequency ablation (RFA) and repeat
hepatic resection (RHR) for recurrent hepatocellular carcinoma (RHCC) remain …

Purpose To compare the long-term outcomes of combined transarterial chemoembolization
and radiofrequency ablation (TACE-RFA) with radiofrequency ablation (RFA) monotherapy …

Methods The study included consecutive 2,067 patients with solitary HCC who were treated
with either ablation (n= 1,248) or surgery (n= 819). Th e patients were divided into three …

Local ablation technologies, such as radiofrequency ablation (RFA), microwave ablation
(MWA) and cryoablation, have become a standard treatment option for hepatocellular …

Background Several treatments are available for treatment of early and very early-stage
Hepatocellular Carcinoma, also known as small Hepatocellular Carcinoma (SHCC) …

Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and a significant global
health burden, with increasing incidence rates and limited treatment options …